Dot Compliance, a provider of AI-enabled Quality Management System (QMS) solutions, today announced it has raised $17.5 million in Series B extension funding, marking a significant up-round. The new round of financing was co-led by existing investors IGP Capital and Vertex Ventures with participation from TPY Capital, and brings total funding to $50 million to date.Doron Sitbon, founder and CEO of Dot Compliance, said: “This funding will allow us to accelerate our momentum and double down on our AI solution.

人工智能质量管理系统（QMS）解决方案提供商Dot Compliance今天宣布，它已在B系列扩展资金中筹集了1750万美元，这标志着一轮重大的升级。新一轮融资由现有投资者IGP Capital和Vertex Ventures共同牵头，TPY Capital参与，迄今为止，融资总额达到5000万美元。Dot Compliance的创始人兼首席执行官多伦·西特本（DoronSitbon）表示：“这笔资金将使我们能够加快发展势头，并在人工智能解决方案上加倍努力。

We are thrilled to be able to offer a solution that makes AI-powered insights accessible to all in the life sciences industry, regardless of what data sources they currently use. Dot Compliance is transforming into a data company as we create a new category of AI-driven compliance.”Dot Compliance will use the proceeds to accelerate its AI software solutions, drive continued product innovation and customer acquisition, and meet escalating market demand for AI-driven solutions that help life sciences organizations improve quality management and meet dynamic compliance requirements. Dr.

我们很高兴能够提供一个解决方案，使生命科学行业的所有人都可以使用人工智能提供的见解，无论他们目前使用的数据源是什么。随着我们创建人工智能驱动的法规遵从性的新类别，Dot法规遵从性正在转变为一家数据公司。”Dot Compliance将利用收益加速其AI软件解决方案，推动持续的产品创新和客户获取，并满足不断增长的市场对AI驱动解决方案的需求，这些解决方案有助于生命科学组织改进质量管理并满足动态合规要求。博士。

Yuval Nardi, Chief Data Scientist of Dot Compliance, said “We are in the midst of an AI revolution with major breakthroughs happening in the last couple of years. Dot Compliance is evolving into a data-centric company, significantly improving quality and compliance processes in the life sciences sector by introducing a groundbreaking, dedicated and fine-tuned AI data pipeline leveraging cutting-edge generative and predictive AI technologies.

Dot Compliance首席数据科学家Yuval Nardi表示：“我们正处于人工智能革命的过程中，过去几年取得了重大突破。Dot Compliance正在发展成为一家以数据为中心的公司，通过引入开创性的、专用的和微调的人工智能数据管道，利用尖端的生成性和预测性人工智能技术，显著提高生命科学领域的质量和合规流程。

This provides our customers with timely, precise, and actionable AI-driven insights tailored to their specific use cases.”Demand is being fueled by the current regulatory and economic environment, in which life sciences organizations need a trusted .

这为我们的客户提供了针对其特定用例量身定制的及时、准确和可行的人工智能驱动见解。”当前的监管和经济环境推动了需求，在这种环境下，生命科学组织需要一个值得信任的人。